Development of novel topical drug delivery system containing cisplatin and imiquimod for dual therapy in cutaneous epithelial malignancy

References

• Bickers DR, Lim HW, Margolis D, et al. (2006). The burden of skin diseases: 2004 a joint project of the American academy of dermatology association and the society for investigative dermatology. J Am Acad Dermatol 55:490–500
   PubMed Web of Science ®Google Scholar
• Brash DE. (1997). Sunlight and the onset of skin cancer. Trends Genet 13:410–14
   PubMed Web of Science ®Google Scholar
• Brash DE, Rudolph JA, Simon JA. (1991). A role for sunlight in skin cancer: UV induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 101:24–8
   Google Scholar
• Burns CA, Brown MD. (2005). Imiquimod for the treatment of skin cancer. Dermat Clinics 23:151–64
   PubMed Web of Science ®Google Scholar
• Cassidy J, Dirix L, Bissett D, et al. (1998). A phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors. Clin Cancer Res 4:2755–61
   PubMed Web of Science ®Google Scholar
• Cevc G. (1996). Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 13:257–388
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. (1992). Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1104:226–32
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. (2003). Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, transfersomes. Biochim Biophys Acta 1614:156–64
   PubMed Web of Science ®Google Scholar
• Cohen JL. (2010). Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer. J Clin Aesthet Dermatol 3:39–44
   PubMedGoogle Scholar
• Das RK, Ugir Hossain SK, Bhattacharya S. (2005). Diphenylmethyl selenocyanate inhibits DMBA–croton oil induced two-stage mouse skin carcinogenesis by inducing apoptosis and inhibiting cutaneous cell proliferation. Cancer Lett 230:90–101
   PubMed Web of Science ®Google Scholar
• Delgado MF, Coviello S, Monsalvo AC, et al. (2009). Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 15:34–41
   PubMed Web of Science ®Google Scholar
• Draize J, Woodard G, Calvery H. (1944). Methods for the study of irritation and toxicity of substances applied to the skin and mucous membranes. J Pharmacol Exp Ther 82:377–90
   Web of Science ®Google Scholar
• Dreher F, Walde P, Luisi PL, Elsner P. (1996). Human skin irritation studies of a lecithin microemulsion gel and of lecithin liposomes. Skin Pharmacol Appl Skin Physiol 9:124–9
   PubMedGoogle Scholar
• Ermolaeva L, Dubskaya TY, Fomina TI, et al. (2008). Toxic effect of an antitumor drug paclitaxel on morphofunctional characteristics of the liver in rats. Bull Exp Biol Med 145:263–5
   PubMed Web of Science ®Google Scholar
• Euvrard S, Kanitakis J, Claudy A. (2003). Skin cancers after organ transplantation. N Engl J Med 345:1681–91
   Google Scholar
• Gupta V, Agrawal RC, Trivedi P. (2011). Reduction in cisplatin genotoxicity (micronucleus formation) in non target cells of mice by protransfersome gel formulation used for management of cutaneous squamous cell carcinoma. Acta Pharm 61:63–71
   PubMed Web of Science ®Google Scholar
• Gupta V, Karthikeyan C, Trivedi P. (2012). Localized delivery of cisplatin for the effective management of squamous cell carcinoma from protransfersome formulation. Arch Pharm Res 35:851–9
   PubMed Web of Science ®Google Scholar
• Gupta V, Trivedi P. (2012). Enhancement of storage stability of cisplatin-loaded protransfersome topical drug delivery system by surface modification with block copolymer and gelling agent. J Drug Del Sci Tech 22:361–6
   Web of Science ®Google Scholar
• Harwood CA, Proby CM. (2002). Human papillomaviruses and nonmelanoma skin cancer. Curr Opin Infect Dis 15:101–14
   PubMed Web of Science ®Google Scholar
• Hengge UR, Benninghoff B, Ruzicka T, Goos M. (2001). Topical immunomodulators—progress towards treating inflammation, infection, and cancer. Lancet Infect Dis 1:189–98
   PubMedGoogle Scholar
• Honeywell-Nguyen PL, Bouwstra JA. (2005). Vesicles as a tool for transdermal and dermal delivery. Drug Discovery Today: Technol 2:67–74
   PubMedGoogle Scholar
• Imbertson LM, Beaurline JM, Couture AM, et al. (1998). Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463. J Invest Dermatol 110:734–9
   PubMed Web of Science ®Google Scholar
• Ingram AJ, Grasso P. (1975). Patch testing in the rabbit using a modified human patch test method. Br J Dermatol 92:131–42
   PubMed Web of Science ®Google Scholar
• Jain S, Kumar D, Swarnakar NK, Thanki K. (2012). Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel. Biomaterials 33:6758–68
   PubMed Web of Science ®Google Scholar
• Jain S, Tiwary AK, Jain NK. (2006). Sustained and targeted delivery of an anti-HIV agent using elastic liposomal formulation: mechanism of action. Curr Drug Deliv 3:157–66
   PubMedGoogle Scholar
• Kanikkannan N, Singh M. (2002). Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Int J Pharm 248:219–28
   PubMed Web of Science ®Google Scholar
• Lashmar UT, Hadgraft J, Thomas N. (1989). Topical application of penetration enhancers to the skin of nude mice: a histopathological study. J Pharm Pharmacol 41:118–21
   PubMed Web of Science ®Google Scholar
• Levy MY, Schutze W, Fuhrer C, Benita S. (1994). Characterization of diazepam submicron emulsion interface: role of oleic acid. J Microencapsul 11:79–92
   PubMed Web of Science ®Google Scholar
• London NJ, Farmery S, Will EJ, et al. (1995). Risk of neoplasia in renal transplant patients. Lancet 346:403–6
   PubMed Web of Science ®Google Scholar
• Merouani A, Davidson SA, Schrier RW. (1997). Increased nephrotoxicity of combination taxol and cisplatin chemotherapy in gynecologic cancers as compared to cisplatin alone. Am J Nephrol 17:53–8
   PubMed Web of Science ®Google Scholar
• Paolino D, Ventura CA, Nistico S, et al. (2002). Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int J Pharm 244:21–31
   PubMed Web of Science ®Google Scholar
• Perrotta ER, Giordano M, Malaguarnera M. (2011). Non-melanoma skin cancers in elderly patients. Criti Rev Oncol/Hematol 80:474–80
   PubMed Web of Science ®Google Scholar
• Pfister H. (2003). Human papillomavirus and skin cancer. J Natl Cancer Inst 31:52–6
   Google Scholar
• Pinnacoda J, Tupker RA, Agner T, Serup J. (1990). Guidelines for transepidermal water loss (TEWL) measurement. Contact Dermat 22:164–78
   PubMed Web of Science ®Google Scholar
• Rabah SO. (2010). Acute taxol nephrotoxicity: histological and ultrastructural studies of mice kidney parenchyma. Saudi J Biol Sci 17:105–14
   PubMedGoogle Scholar
• Rossi R, Mori M, Lotti T. (2007). Actinic keratosis. Int J Dermatol 46:895–904
   PubMed Web of Science ®Google Scholar
• Sabithaa M, Rejinolda NS, Naira A, et al. (2013). Development and evaluation of 5-fluorouracil loaded chitin nanogels for treatment of skin cancer. Carbohydrate Polym 91:48–57
   PubMed Web of Science ®Google Scholar
• Smith KJ, Hamza S, Skelton H. (2004). Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg 30:634–41
   PubMed Web of Science ®Google Scholar
• Trotta M, Peira E, Carlotti ME, Gallarate M. (2004). Deformable liposomes for dermal administration of methotrexate. Int J Pharm 270:119–25
   PubMed Web of Science ®Google Scholar
• Ulrich M, Krueger-Corcoran D, Roewert-Huber J, et al. (2010). Reflectance confocal microscopy for noninvasive monitoring of therapy and detection of subclinical actinic keratoses. Dermatology 220:15–24
   PubMed Web of Science ®Google Scholar
• Vellaichamy L, Balakrishnan S, Panjamurthy K, et al. (2009). Chemopreventive potential of piperine in 7,12-dimethylbenz[a]anthraceneinduced skin carcinogenesis in Swiss albino mice. Environ Toxico Pharmacol 28:11–18
   PubMed Web of Science ®Google Scholar
• Wagner TL, Horton VL, Carlson GL, et al. (1997). Induction of cytokines in cynomolgus monkeys by the immune response modifiers imiquimod, S-27609 and S-28463. Cytokine 9:837–45
   PubMed Web of Science ®Google Scholar
• Yoo HS, Lee KH, Oh JE, Park TG. (2000). In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J Contr Rel 68:419–31
   PubMed Web of Science ®Google Scholar